MoneyWorks4Me

Lasa Supergenerics informs about closure of trading window

04 Jul 2019 Evaluate

Lasa Supergenerics has informed that as per the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives with effect from July 01, 2019 till 72 hours after the declaration of financial results for the quarter ended on June 30, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..